Mount Gilead State Park provides beautiful natural settings for walking off those donut calories, with trails that showcase Ohio’s landscape through the seasons. The town itself contains charming ...

Mount Gilead State Park provides beautiful natural settings for walking off those donut calories, with trails that showcase ...

Australia's multicultural and multilingual broadcaster. Includes news, sport, entertainment, documentary, film, food, radio ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S. PrEP users by 2035.

Gilead Sciences is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV resulting from the company’s long-running collaboration with Hookipa Pharma.

A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors who spoke at sponsored events.

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle civil claims that the drugmaker used speaker programs to pay kickbacks to doctors to induce them to ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why I downgraded GILD stock to Hold.

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $6.67 billion. The company’s full-year revenue ...

Gilead's dominance in HIV faces Medicare pricing challenges, limiting growth.

Gilead will not move forward with Arcus Biosciences’ casdatifan, an investigational HIF-2a blocker that is being tested for kidney cancer. As per the California biotech’s Tuesday press announcement, ...